A Study to Evaluate the Efficacy and Safety of BLI5100 in Patients With Erosive Esophagitis

Clinical trial NCT05587309 · COMPLETED

Trial details

NCT number: NCT05587309
Sponsor: Braintree Laboratories
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Erosive Esophagitis

Start date: 2022-10-30
Primary completion: 2025-06-16
Enrollment: 1250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.